Winning Its Third Consecutive Plus X Award, EZVIZ Made a Strong Testament to Its User-centric Smart Home Innovation That Makes Impacts
HOOFDDORP, Netherlands–(BUSINESS WIRE)–EZVIZ, a smart home brand driven by innovation, announced that it has received recognition from the distinguished... Read more.
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$ZTS—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$ZTS—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$ZTS—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
KBank and Ant International Partner on Cross-Border Payments and Liquidity Management in Thailand
KBank will combine its banking capabilities with Ant International’s finAI solutions to enhance cross-border payments and treasury management for Ant International’s... Read more.
CALX Investors Have Opportunity to Lead Calix, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$CALX—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
Faraday Future Submits Regulatory Referral Letter to the SEC, Advancing Fight Against Alleged Illegal Short Selling and Market Manipulation Including Alleged Conduct by Hua Qixin and Associates
As a key milestone in the Company’s ongoing efforts against alleged illegal short selling, FF has formally submitted a Regulatory Referral Letter to the U.S. Securities... Read more.
AGC Completes Third-Party Verification Under UL 2809 for Fluorine Raw Materials Used in AFLAS™ FFKM
－Fluorine Content attributed as 100% “Recycled Circular Fluorite” Based on Mass Balance Credit Allocation－ TOKYO–(BUSINESS WIRE)–#FFKM–AGC... Read more.
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
Based on POTOMAC Phase III trial results which showed a 32% reduction in the risk of high-risk disease recurrence, progression or death after one year of IMFINZI... Read more.
Navan to Announce First Quarter Fiscal 2027 Financial Results on June 10, 2026
PALO ALTO, Calif.–(BUSINESS WIRE)–Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it will report... Read more.